SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012644
Filing Date
2016-04-28
Accepted
2016-04-28 06:14:28
Documents
12
Period of Report
2016-06-21
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228299zdef14a.htm DEF 14A 889967
2 G202915.JPG g202915.jpg GRAPHIC 17152
3 G1012795.JPG g1012795.jpg GRAPHIC 6628
4 G333825.JPG g333825.jpg GRAPHIC 5367
5 G559833.JPG g559833.jpg GRAPHIC 5883
6 G292213.JPG g292213.jpg GRAPHIC 6245
7 G79461.JPG g79461.jpg GRAPHIC 40347
8 G900887.JPG g900887.jpg GRAPHIC 60253
9 G24472BEI001.GIF g24472bei001.gif GRAPHIC 64317
10 G24472BEI002.GIF g24472bei002.gif GRAPHIC 81512
11 G24472BGI001.GIF g24472bgi001.gif GRAPHIC 74744
12 G24472BGI002.GIF g24472bgi002.gif GRAPHIC 88956
  Complete submission text file 0001047469-16-012644.txt   1514181
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26301 | Film No.: 161596988
SIC: 2834 Pharmaceutical Preparations